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ABSTRACT

Tonsillectomy with or without adenoidectomy is one of the most frequently performed surgeries in the
United States, with over 500,000 performed annually. Post-tonsillectomy hemorrhage is one of the most
feared complications; thus, medications that could increase the risk of postoperative bleeding traditionally
have been avoided. With recent FDA guidelines encouraging a departure from codeine-based medications
in pediatric patients undergoing tonsillectomy, we examined the use of ibuprofen for post-tonsillectomy
pain control. The records of 449 children who underwent tonsillectomy and received ibuprofen for
postoperative pain control were reviewed and compared to a cohort of 1731 children who received
codeine for pain postoperatively. Outcomes measured included rates of secondary post-tonsillectomy
hemorrhage (PTH), secondary PTH requiring operative control, and emergency room evaluation for
dehydration. Use of ibuprofen after pediatric intracapsular tonsillectomy was found to be associated with a
statistically significant increase in secondary PTH and secondary PTH requiring operative
control; however, ibuprofen was found to provide pain control that is at least equivalent to narcotic. Rates
of secondary PTH with postoperative ibuprofen use remain within the national average. We propose that,
despite the increased risk of bleeding, the use of ibuprofen is appropriate for use postoperatively in
pediatric tonsillectomy patients, given its ability to control pain and lack of respiratory depression effects.

RESULTS

DISCUSSION

Table 1. Comparison of Outcome Measures for Narcotic and NSAID Groups
Narcotic
(n = 1731)

NSAIDs
(n = 449)

P value

Secondary PTH

19 (1.1%)

17 (3.8%)

< 0.0001

Secondary PTH
requiring operative
control

8 (0.5%)

7 (1.6%)

0.01

Dehydration

52 (3%)

19 (4.2%)

0.23

INTRODUCTION
Post-tonsillectomy pain traditionally has been controlled with acetaminophen in
combination with a narcotic, such as codeine, hydrocodone, or oxycodone. Deaths
due to respiratory depression have been reported in children given codeine posttonsillectomy.1 Many of the deaths have been in children who possess forms of the
liver microenzyme CYP2D6 that make them extensive or ultrarapid metabolizers of
codeine.2
The current concerns regarding rapid metabolism of codeine products in children
following tonsillectomy3 have led to widespread reconsideration of posttonsillectomy pain management regimens for the pediatric population. Nonsteroidal anti-inflammatory drugs (NSAID), specifically ibuprofen, have gained favor
as an alternative to narcotics for postoperative pain control. While NSAIDs provide
adequate post-tonsillectomy analgesia,4 their routine use remains controversial as
NSAIDs also cause platelet dysfunction that may lead to increased risk of posttonsillectomy hemorrhage (PTH). The clinical impact of this potentially increased
bleeding risk with NSAID use remains unclear.
This study examines whether the use of ibuprofen in children post-intracapsular
tonsillectomy affects the likelihood of clinically significant bleeding. The incidence of
PTH requiring either non-surgical or surgical intervention is compared in children
who received ibuprofen and acetaminophen versus those who received
acetaminophen with narcotic for post-tonsillectomy pain. Secondarily, the incidence
of emergency department (ED) evaluation for pain or poor oral intake is examined.

METHODS
A sample of children who underwent tonsillectomy or adenotonsillectomy for
infections or sleep-disordered breathing at Nemours/Alfred I. duPont Hospital for
Children (N/AIDHC) between 2011 and 2013 was reviewed. Intracapsular
tonsillectomy was performed on all children. Postoperatively, families received
verbal and written instruction to use alternating acetaminophen and ibuprofen as
needed for their child’s pain. This cohort of children was then compared to a cohort
of children who underwent intracapsular tonsillectomy or adenotonsillectomy at
N/AIDHC between 2002 and 2005 who used acetaminophen with codeine or
hydrocodone as needed for pain.5 Data collected included patient age and gender;
indication for surgery; use of postoperative ketorolac; occurrence of primary or
secondary PTH; evaluation in the ED for PTH, pain, or poor oral intake; and need
for reoperation due to secondary PTH. Children with known coagulopathies were
excluded. The association between categorical variables was expressed as odds
ratios (OR) with 95% confidence intervals. Differences in the relative proportions
between categorical variables were analyzed using Fisher exact test and chisquare analysis, as appropriate.

Table 2. Postoperative Ketorolac Use and Post-Tonsillectomy Hemorrhage
Ketorolac Used
(n = 161)

No Ketorolac Used
(n = 288)

P value

Primary PTH

4 (4.3%)

5 (1.7%)

0.73

Secondary PTH

5 (3.1%)

12 (4.2%)

0.80

There were 449 patients studied who underwent tonsillectomy or
adenotonsillectomy at N/AIDHC between 2011 and 2013 (NSAID group). Of these,
244 (54.3%) were female, and 205 (45.7%) were male; the mean age at time of
surgery was 9.5 years (SD, 3.2 years). The secondary data set examined 1731
patients who underwent intracapsular tonsillectomy or adenotonsillectomy at
N/AIDHC between 2002 and 2005 (Narcotic group). Forty-eight percent were
female, and 52% were male; the mean age at time of surgery was 6 years.
There were 7 (3.8%) episodes of secondary PTHs in the NSAID group and 19
(1.1%) episodes of secondary PTHs in the Narcotic group, a difference that was
statistically significant (P < 0.0001, OR 3.5, 95% CI 1.7–7.2). In the NSAID group,
seven (1.6%) required control of their PTH in the operating room, as compared to
eight (0.5%) in the Narcotic group. The increased rate of PTH requiring control in
the operating room was significantly higher in the NSAID group (P = 0.01, OR 3.4,
95% CI 1.1–10.1). In the NSAID group, 161 patients received ketorolac
postoperatively for pain control, and 288 did not. In those who received ketorolac,
there were four (4.3%) episodes of primary PTH and five (3.1%) episodes of
secondary PTH. Of those not receiving ketorolac, there were five (3.1%) with
primary PTH and 12 (4.2%) with secondary PTH. Administration of ketorolac was
found to have no statistically significant effect on rates of primary (P = 0.73) or
secondary (P = 0.80) PTH.
In the NSAID group, 19 of 512 (3.71%) patients were evaluated in the ED for pain
or poor oral intake. In the narcotic group, 52 of 1731 (3.79%) were admitted for
dehydration. The incidence of ED evaluation for pain or poor oral intake was not
statistically significant between groups (P = 0.23).

Nemours is an internationally recognized children’s health system that owns and operates the Nemours/Alfred I. duPont Hospital for Children in Wilmington, DE, along
with major pediatric specialty clinics in Delaware, Florida, Pennsylvania, and New Jersey. In October, 2012, it opened the full-service Nemours Children’s Hospital in
Orlando, Florida. To learn more about Nemours, visit www.Nemours.org.

Several studies have been undertaken in recent years to evaluate the increased
risk of PTH in children using NSAIDs, and suggest that there is evidence that
NSAIDs increase this risk.6-10 In a 2003 study by Marrett, the preoperative use of
NSAIDs was associated with increased risk of reoperation for hemostasis versus
those who received placebo or narcotic.6 A study by Møiniche that same year found
that postoperative NSAID use leads to increased likelihood of having a PTH
requiring reoperation.7 A more recent systematic review and meta-analysis by
Riggin10 again found that patients receiving NSAIDs in the postoperative period
have an increased risk for PTH. Limitations of these studies include the use of
several different NSAID agents and inclusion of both pediatric and adult patients.
The current study examines differences in a pediatric population who underwent
intracapsular tonsillectomy and for whom parents received standard verbal and
written instruction regarding the recommended postoperative pain regimen. In our
population, patients receiving postoperative ketorolac and ibuprofen had a
statistically significant higher rate of secondary PTH with no increased bleeding
attributed to use of ketorolac. Despite the observed increase in PTH, the overall
rate of PTH and PTH requiring operative control remain within the national
average. The relative increase in PTH must be weighed against the risks of
respiratory depression associated with postoperative codeine use, especially in the
pediatric sleep-disordered breathing population.
A limitation of our study involves variation in the dosage of ibuprofen administered;
with some surgeons prescribing 5 mg/kg/dose and others 10 mg/kg/dose. As a
retrospective study, the number of NSAID doses actually taken also remains
unknown. Both limitations will be addressed in a future prospective study. Finally, it
is noteworthy that in the narcotic group, children evaluated in the ED for
hyperemesis thought to be due to codeine were not considered in the dataset. As
such, it is possible that the difference in the number of children in the NSAID group
and narcotic group presenting to the ED for nausea and vomiting, noted to be not
significantly different, is underestimated.

CONCLUSION
The debate on the ideal pain control regimen for children post-tonsillectomy
persists. Our review suggests that NSAIDs increase the likelihood of clinically
significant, secondary PTH; the rate of secondary PTH observed, however, still falls
within national averages. Conversely, NSAIDs appear to provide adequate pain
relief, resulting in at least an equivalent incidence of ED evaluation for poor oral
intake as compared to narcotic, and not conferring an increased risk for
suppression of respiratory drive. Future studies aim to evaluate whether the
number of doses and the amount of ibuprofen given per dose affects risk for PTH
and to continue to examine the effects of ketorolac on primary and secondary PTH.
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